← Evidence map

ArticleLeukemia2026

A STAT3 degrader demonstrates efficacy in venetoclax resistant acute myeloid leukemia.

Samarpana Chakraborty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41703028